Tag: contrast agent
ACR Committee on Drugs and Contrast Media classifies Elucirem injection a...
Guerbet has announced in a press release that based on the most recent scientific and clinical evidence, the American College of Radiology (ACR) Committee...
Guerbet announces first patient dosing with Elucirem for contrast-enhanced MRI
Guerbet has shared in a press release that it has commercially launched Elucirem (gadopiclenol) and the first patient has received a dosing. This is...
Guerbet releases first batch of Elucirem for contrast-enhanced MRI
Guerbet has announced the first production batch has been manufactured and released for Elucirem (gadopiclenol) injection following US Food and Drug Administration (FDA) approval...
Guerbet announces US Food and Drug Administration approval of Elucirem
Guerbet announced that the US Food and Drug Administration (FDA), after priority review, has approved Elucirem (Gadopiclenol), a new macrocyclic gadolinium-based contrast agent (GBCA)...
